Randomized trial of Alvarado score and antibiotics therapy as a corporate protocol versus conventional clinical management for acute appendicitis

ISRCTN ISRCTN23935876
DOI https://doi.org/10.1186/ISRCTN23935876
Secondary identifying numbers N/A
Submission date
23/02/2007
Registration date
02/04/2007
Last edited
30/10/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Mohammadreza Farahnak
Scientific

Department of Surgery, 22 Bahman Hospital
Imam street
Masjedsoleiman
19674
Iran

Study information

Study designRandomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Scientific title
Study objectivesThis study aims to compare incorporating the Alvarado score and outpatient antibiotics with conventional clinical management in the treatment of acute appendicitis.
Ethics approval(s)22 Bahman Hospital ethics committee, approved on 16 May 2006. Ref: 1014/19
Health condition(s) or problem(s) studiedAcute appendicitis
InterventionThe patients will be randomized according to a computer-generated randomization list into case and control group. The Alvarado score is calculated for both groups by a general practitioner not involved in other stages of the study. The Alvarado scores of the patients in the control group will not be known to the admitting service and surgical team. They will continue with conventional clinical assessment and management. The admitting service and the surgical team are informed of the Alvarado scores of patients in the case group. Afterward, patients of the case group will be divided into 3 management subgroups according to their own Alvarado scores: Subgroup 1 - Alvarado score 4 or less. Discharge, no follow up. Subgroup 2 - Alvarado score 5 to 7. Outpatient antibiotics and observation if practicable. They will be prescribed one dose of intravenous gentamicin, 6 mg/kg, and metronidazole, 500 mg for adults or 15 mg/kg as a loading dose for children. Afterward, patients will be discharged on a 10-day course of co-amoxiclav 625 tablets 3 times daily for adults and oral suspension of co-amoxiclav 312.5, 25 mg/kg per day in divided doses every 8 hours for children (Farabi Pharmaceutical Co, Iran). They will be asked to attend 1 day in the clinic. Subgroup 3 - Alvarado score 8 to 10. Immediate operation. They will be immediately arranged to undergo emergency surgery after intravenous injection of antibiotics loading dose as mentioned above.
Intervention typeOther
Primary outcome measure1. Time to surgery, from randomization to skin preparation in hours
2. Duration of hospitalization, from randomization to discharge from hospital or emergency service (for out-patients) in hours
Secondary outcome measures1. Admission rate
2. Operation rate
3. Nontherapeutic surgeries rate (surgery is called therapeutic when it finds the cause of patient’s pain and it is pertinent to cure the problem)
4. Perforation with late treatment (PLT) rate (treatment that begins at least 10 hours after randomization is considered late)
Overall study start date10/07/2006
Completion date01/04/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants188
Key inclusion criteria1. Older than 6 years
2. Admitted initially for the current abdominal pain
Key exclusion criteria1. Generalized peritonitis
2. Suspected of having any abdominal mass or any abdominal involvement of degenerative or systemic diseases
3. Evidence of any mental disturbances, acute confusional state, or dementia
4. Already have any imaging document including plain radiography, ultrasonography, or computed tomographic scan
5. Patients, children’s parent(s), or admitting surgeon repudiate entry into the study
Date of first enrolment10/07/2006
Date of final enrolment01/04/2007

Locations

Countries of recruitment

  • Iran

Study participating centre

Department of Surgery, 22 Bahman Hospital
Masjedsoleiman
19674
Iran

Sponsor information

Bahman Hospital (Iran)
Hospital/treatment centre

Department of Surgery
22 Bahman Hospital
Imam street
Masjedsoleiman
1967
Iran

Funders

Funder type

Hospital/treatment centre

Department of Surgery, 22 Bahman Hospital (Iran)

No information available

Department of Surgery, Iran University of Medical Sciences (Iran)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Other publications publication 01/09/2007 Yes No